Lv1
60 积分 2024-05-08 加入
From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation
16小时前
已完结
Annual review of PROTAC degraders as anticancer agents in 2022
16小时前
已完结
Review of the impact of fragment-based drug design on PROTAC degrader discovery
16小时前
已完结
Structural and Physicochemical Features of Oral PROTACs
16小时前
已完结
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation
16小时前
已完结
Routes to molecular glue degrader discovery
17小时前
已完结
Next-Generation Cancer Therapeutics: PROTACs and the Role of Heterocyclic Warheads in Targeting Resistance
1个月前
已完结
Next steps for targeted protein degradation
2个月前
已完结
Lessons from natural molecular glue degraders
2个月前
已完结
Lessons from natural molecular glue degraders
2个月前
已完结
皖公网安备34019202002308
